Amy Arnold, PhD
Pennsylvania State University College of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Amy Arnold, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:58 UTC. Open this list on ClinicalTrials.gov
- Early Ph1NCT06482853 · Cardiovascular Effects of Angiotensin-(1-7) in Obesity HypertensionMilton S. Hershey Medical Center · recruiting · Obesity, Hypertension · principal investigator
- Early Ph1NCT05301192 · Angiotensin-(1-7) Cardiovascular Effects in AgingMilton S. Hershey Medical Center · terminated · Aging · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Angiotensin-(1-7) and Cardiovascular Derangements in Obesity HypertensionR01HL170140 · NHLBI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI Amy C Arnold, Alfredo Gamboa · fiscal years 2024 to 2026Named on NCT06482853
- Angiotensin-(1-7) and beta adrenergic receptor signaling in agingK99HL159272 · NHLBI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI Amanda Joy Miller · fiscal years 2022 to 2023Named on NCT05301192
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.